Cycloartane-3,24,25-triol inhibits MRCKα kinase and demonstrates promising anti prostate cancer activity in vitro

BackgroundGiven the high occurrence of prostate cancer worldwide and one of the major sources of the discovery of new lead molecules being medicinal plants, this research undertook to investigate the possible anti-cancer activity of two natural cycloartanes; cycloartane-3,24,25-diol (extracted in our lab from Tillandsia recurvata) and cycloartane-3,24,25-triol (purchased). The inhibition of MRCKα kinase has emerged as a potential solution to restoring the tight regulation of normal cellular growth, the loss of which leads to cancer cell formation.MethodsKinase inhibition was investigated using competition binding (to the ATP sites) assays which have been previously established and authenticated and cell proliferation was measured using the WST-1 assay.ResultsCycloartane-3,24,25-triol demonstrated strong selectivity towards the MRCKα kinase with a Kd50 of 0.26 μM from a total of 451 kinases investigated. Cycloartane-3,24,25-triol reduced the viability of PC-3 and DU145 cell lines with IC50 values of 2.226 ± 0.28 μM and 1.67 ± 0.18 μM respectively.ConclusionsThese results will prove useful in drug discovery as Cycloartane-3,24,25-triol has shown potential for development as an anti-cancer agent against prostate cancer.

• Publication year

  2012

• Venue

  Cancer Cell International

• Publication date

  2012-11-14

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1186/1475-2867-12-46PMID 23151005PMCID 3520828
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cycloartane-3,24,25-triol inhibits MRCKα kinase and demonstrates promising anti prostate cancer activity in vitro

  2012cited by this paper
• Global cancer statistics

  2011cited by this paper
• Co-Crystal Structures of Inhibitors with MRCKβ, a Key Regulator of Tumor Cell Invasion

  2011cited by this paper
• Effects of the ErbB1/ErbB2 kinase inhibitor GW2974 on androgen-independent prostate cancer PC-3 cell line growth and NSE, chromogranin A and osteopontin content.

  2010cited by this paper
• WST-1-based cell cytotoxicity assay as a substitute for MTT-based assay for rapid detection of toxigenic Bacillus species using CHO cell line.

  2008cited by this paper
• A quantitative analysis of kinase inhibitor selectivity

  2008cited by this paper
• Cancer chemopreventive effects of cycloartane-type and related triterpenoids in in vitro and in vivo models.

  2007cited by this paper
• Rho GTPases: biochemistry and biology.

  2005cited by this paper
• Cdc42–MRCK and Rho–ROCK signalling cooperate in myosin phosphorylation and cell invasion

  2005cited by this paper
• A small molecule–kinase interaction map for clinical kinase inhibitors

  2005cited by this paper
• Rho GTPases in human cancer: an unresolved link to upstream and downstream transcriptional regulation.

  2004cited by this paper
• ROCK and Dia have opposing effects on adherens junctions downstream of Rho

  2002cited by this paper
• Rho GTPases and the actin cytoskeleton.

  1998cited by this paper
• Hydroperoxycycloartanes from Tillandsia recurvata

  1995cited by this paper
• Effects of fatty acids and eicosanoid synthesis inhibitors on the growth of two human prostate cancer cell lines

  1991cited by this paper
• A NOTE ON MID-CRETACEOUS GEOGRAPHY.

  1906cited by this paper

• Synthesis of Cycloartan‐16β‐ol from 16β 24R‐Epoxy‐Cycloartane and Their Cytotoxicity Evaluation Against Human Cancer Cell Lines

  2024cites this paper
• Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance

  2023cites this paper
• Characterization of Anticancer Effects of the Analogs of DJ4, a Novel Selective Inhibitor of ROCK and MRCK Kinases

  2023cites this paper
• Isolation and Identification of Flavones Responsible for the Antibacterial Activities of Tillandsia bergeri Extracts

  2022cites this paper
• A new horizon for the steroidal alkaloid cyclovirobuxine D (huangyangning) and analogues: Anticancer activities and mechanism of action

  2020cites this paper
• The Chemical Structure and Bioactivity of Cycloartane-type Compounds

  2020cites this paper
• The flower head of Chrysanthemum morifolium Ramat. (Juhua): A paradigm of flowers serving as Chinese dietary herbal medicine.

  2020cites this paper
• The Tillandsia genus: history, uses, chemistry, and biological activity

  2019influential citation
• HLBT-100: a highly potent anti-cancer flavanone from Tillandsia recurvata (L.) L.

  2017cites this paper
• Analysis of natural product regulation of opioid receptors in the treatment of human disease.

  2017cites this paper
• Study of phytochemical, anti-microbial, anti-oxidant, and anti-cancer properties of Allium wallichii

  2017cites this paper
• Afzelin exhibits anti-cancer activity against androgen-sensitive LNCaP and androgen-independent PC-3 prostate cancer cells through the inhibition of LIM domain kinase 1.

  2015cites this paper
• Approaches of targeting Rho GTPases in cancer drug discovery

  2015influential citation
• The regulatory roles of ROCK and MRCK kinases in the plasticity of cancer cell migration.

  2015cites this paper
• Unearthing the medicinal properties of Tillandsia recurvata (Ball Moss): a mini review.

  2014cites this paper
• Synthesis of Substituted 1,3-Diesters of Glycerol Using Wittig Chemistry

  2014cites this paper
• Specific RSK kinase inhibition by dibenzyl trisulfide and implication for therapeutic treatment of cancer.

  2014cites this paper
• Cycloartanes with anticancer activity demonstrate promising inhibition of the Mrckα and Mrckβ kinases.

  2014influential citation
• Natural products from resurrection plants: potential for medical applications.

  2014cites this paper
• The actin-myosin regulatory MRCK kinases: regulation, biological functions and associations with human cancer

  2014cites this paper
• Molecular Pathways: Targeting the Kinase Effectors of RHO-Family GTPases

  2014cites this paper
• Cycloartanes with anticancer activity 2 demonstrate promising inhibition of the MRCKα 3 and MRCKβ kinases 4 5

  2013influential citation
• Anti-proliferative effect of terpenes on human prostate cancer cells : Natural sources and their potential role as chemopreventive agents

  year unknowncites this paper